Low level of serum HDL-cholesterol with increased sIL-2R predicts a poor clinical outcome for patients with malignant lymphoma and adult T-cell leukemia-lymphoma.

Ichiro Komiya,Takeaki Tomoyose,Gen Ouchi, Tomohiro Yara, Seishou Higa

Cytokine（2018）

引用 13|浏览20

暂无评分

摘要

•Low serum HDL-cholesterol suggested the disease activity at the onset.•Poorer outcome indicator in malignant lymphoma or adult T-cell leukemia and lymphoma.•High serum soluble interleukin-2 receptor provided a reliable marker of disease extent.•Inverse correlation between HDL-cholesterol and soluble interleukin-2 receptor.

查看译文

关键词

HDL-C,Clinical outcome,Soluble IL-2R,Hematological malignancy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要